[HTML][HTML] Adjuvant chemotherapy for stage III colon cancer

J Taieb, C Gallois - Cancers, 2020 - mdpi.com
Simple Summary In patients with stage III colon cancer, adjuvant chemotherapy with a
fluoropyrimidine combined with oxaliplatin reduces the risk of recurrence and mortality, with …

[HTML][HTML] Adjuvant chemotherapy for stage II colon cancer

SE Rebuzzi, G Pesola, V Martelli, AF Sobrero - Cancers, 2020 - mdpi.com
Simple Summary Stage II colon cancer is defined as an early stage of the tumor disease,
without the involvement of lymph nodes or distant organs. In this group of patients, surgery …

Association of sarcopenia with relative dose intensity of neoadjuvant chemotherapy in older patients with locally advanced esophageal cancer: a retrospective cohort …

T Harada, T Tsuji, J Ueno, N Hijikata, A Ishikawa… - Journal of Geriatric …, 2023 - Elsevier
Introduction Sarcopenia impacts the toxicity of chemotherapy in patients with cancer, but
there is little information on the association of sarcopenia with the relative dose intensity …

[HTML][HTML] Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR …

T Lecomte, D Tougeron, R Chautard… - Digestive and Liver …, 2024 - Elsevier
Introduction This article is a summary of the French intergroup guidelines regarding the
management of non-metastatic colon cancer (CC), revised in November 2022. Methods …

Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review

KKF Cheng, EYT Lim, R Kanesvaran - BMJ open, 2018 - bmjopen.bmj.com
Objectives The measurement of quality of life (QoL) in elderly cancer population is
increasingly being recognised as an important element of clinical decision-making and the …

A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring—supporting patients in their homes

A Weaver, SB Love, M Larsen, M Shanyinde… - Supportive Care in …, 2014 - Springer
Purpose Real-time symptom monitoring using a mobile phone is potentially advantageous
for patients receiving oral chemotherapy. We therefore conducted a pilot study of patient …

[HTML][HTML] Pharmacokinetics of selected anticancer drugs in elderly cancer patients: focus on breast cancer

MRBS Crombag, M Joerger, B Thürlimann… - Cancers, 2016 - mdpi.com
Background: Elderly patients receiving anticancer drugs may have an increased risk to
develop treatment-related toxicities compared to their younger peers. However, a potential …

Factors predicting adherence to a tailored-dose adjuvant treatment on the basis of geriatric assessment in elderly people with colorectal cancer: a prospective study

M Antonio, A Carmona-Bayonas, J Saldana… - Clinical colorectal …, 2018 - Elsevier
Background Selecting elderly people with colorectal cancer (CRC) for adjuvant
chemotherapy is challenging. Comprehensive geriatric assessment (CGA) can help by …

[HTML][HTML] Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective

SS Ali, R Raj, T Kaur, B Weadick, D Nayak, M No… - Cancers, 2022 - mdpi.com
Simple Summary Anticancer nucleoside analogs are promising treatments that often result
in damaging toxicities and therefore ineffective treatment. Mechanisms of this are not well …

Guidance for Treating the Older Adults with Colorectal Cancer

D Ioffe, E Dotan - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement The need for evidence-based data in the rapidly growing group of older
patients is vast and more elderly-specific studies are desperately needed, for which there is …